← All stocks

HERON THERAPEUTICS, INC. /DE/

HRTX No buying or selling

CIK 0000818033 #4644 in the set updated 21 Sep 2026

Bought (1 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$0.00

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 0 sales

Net

$0.00

$0.00 against sales at will

By person

12 insiders · 0 transactions

Insider

Role

Bought

Sold

Net

Holding

Worth

Change

Rubric Capital Management LP entity

10% owner

—

30,046,828

$45.07M

+12.5%

Morgan Adam

Director

—

8,877,027

$13.32M

+26.1%

Collard Craig A

Chief Executive Officer

—

856,492

$1.28M

+174.2%

Duarte Ira

EVP, Chief Financial Officer

—

281,899

$422.85K

+100.6%

Forbes William P

EVP, Chief Development Officer

—

241,173

$361.76K

+143.0%

Hensley Mark Earl

Chief Operating Officer

—

170,901

$256.35K

—

Rodriguez Susan

Director

—

87,180

$130.77K

+25.9%

Kaseta Michael

Director

—

53,960

$80.94K

—

Johnson Craig A

Director

—

53,960

$80.94K

—

Christian Waage

Director

—

53,960

$80.94K

—

Cusack Thomas

Director

—

53,960

$80.94K

—

Dissanaike Sharmila

Director

—

53,960

$80.94K

—

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 0

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 0

History held since 7 Oct 2016